Tiagabine
Gabitril (tiagabine) is a small molecule pharmaceutical. Tiagabine was first approved as Gabitril on 1997-09-30. It is used to treat bipolar disorder, epilepsy, and partial epilepsies in the USA. The pharmaceutical is active against sodium- and chloride-dependent GABA transporter 1.
| Trade Name | Gabitril |
|---|---|
| Common Name | Tiagabine |
| Indication | bipolar disorder, epilepsy, partial epilepsies |
| Drug Class | Gabamimetics |
